Affinivax, Inc.

Biotechnology company · Cambridge, Massachusetts, United States

Affinivax, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2014. It has reported private securities offerings to the US SEC, most recently $226 million sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Affinivax at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Earliest incorporation on record2014

SEC industryBiological Products, (No Diagnostic Substances)

SEC CIK1726931

What does Affinivax do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $226 million sold (2021).

Frequently asked questions about Affinivax

Where is Affinivax headquartered?

Affinivax, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Affinivax do?

Affinivax, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

When was Affinivax founded?

The earliest incorporation on record for Affinivax, Inc. is in 2014, according to public company registers.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences